Le Lézard
Classified in: Health, Covid-19 virus
Subjects: AWD, NPT, SCZ

Central Baptist Village Ranks Among America's Best Nursing Homes


NORRIDGE, Ill., Oct. 27, 2023 /PRNewswire/ -- Central Baptist Village (CBV), a senior living community in Norridge, Illinois, has made the list of America's Best Nursing Homes for 2024 published by Newsweek.

Central Baptist Village ranks among the best nursing homes. CBV also offers assisted living and memory care.

Newsweek's annual rankings are based on five data sources, including performance data, peer recommendations, management of the COVID-19 situation, and accreditations from The Joint Commission and Commission on Accreditation of Rehabilitation Facilities. For the first time, resident satisfaction data for nursing homes, based on National Safety Goals from The Joint Commission and Google Scores, has been added to the scoring model.

"We are honored to be counted among the best nursing homes in America," said CBV Administrator Jon Ragsdale. "It is a testament to our exceptional staff that takes immense pride in putting our residents' needs first, doing even the smallest things with great care, and showing their Heart to Serve every day at CBV."

In addition to Newsweek's ranking, CBV also enjoys the highest overall 5-star rating issued by The Centers for Medicare and Medicaid Services agency. CMS created the Five-Star Quality Rating System to help consumers, their families, and caregivers compare nursing homes more easily.

CBV has a 127-year tradition of serving and celebrating seniors. Founded in 1896, CBV provides holistic care that encompasses the physical, cognitive, social, and spiritual needs of residents.

Central Baptist Village offers a continuum of care under one roof?Assisted Living and Memory Support in The Commons, Sheltered Care for higher clinical and memory needs in The Terrace, and Skilled Nursing and Certified Dementia Care in The Pavilion.

About Central Baptist Village 
Central Baptist Village is a senior retirement community offering assisted living, memory care, short-term rehabilitation, and CMS 5-star rated skilled nursing. A senior living community unlike any other, CBV's residences, programs, and care are exceptional, award-winning, and progressive. As a non-profit organization, CBV is empowered to lead from the heart, not the bottom line. For more information, visit www.cbvillage.org.

For more information, contact

Mary Dalton
708.583.8527
[email protected]

SOURCE Central Baptist Village


These press releases may also interest you

at 18:14
SARC LAUNCHES GLOBAL SARCOMA CENTERS REGISTRY SUPPORTING PATIENT AND CLINICIAN ACCESS TO PROGRAMS EXPERT IN THE DIAGNOSIS AND TREATMENT OF SARCOMA (RARE AND ULTRARARE CANCER TYPES COMPRISING 15-20% OF CHILDHOOD CANCERS AND 1% OF ADULT CANCERS)
SARC (Sarcoma Alliance for Research Through Collaboration) is proud to announce the launch of the Sarcoma Centers Registry https://sarctrials.org/sarcoma-centers/, a comprehensive, global resource facilitating...

at 18:08
Genprex Announces the Passing of its Co-Founder and Chief Executive Officer, Rodney Varner
Genprex, Inc. ("Genprex" or the "Company") , a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced with great respect and sorrow the unexpected passing last night of...

at 18:02
Indigenous Services Canada announces 2024 recipients of Award of Excellence in Nursing
It takes a unique, special kind of dedication to become a nurse. For the nurses in First Nations and Inuit communities, it takes strength, resiliency, expertise, and most importantly, heart. It takes an understanding of the complex environment of...

at 17:44
EDWARD C. SWEENEY HONORED AT THE CENTER FOR DISCOVERY'S ANNUAL EVENING OF DISCOVERY GALA
On Tuesday, May 7, 2024, The Center for Discovery® (TCFD, The Center) honored Edward C. Sweeney, TCFD Board Chair, at the 24th annual Evening of Discovery Gala. The Gala was hosted by Mo Rocca, CBS Sunday Morning Correspondent, Humorist, and Creator...

at 17:30
Phanes Therapeutics, Inc. Announces Clinical Supply Agreement with Roche to Evaluate PT217 in Combination with an anti-PD-L1 Therapy
PT217 is Phanes' first-in-class bispecific antibody targeting DLL3 and CD47; atezolizumab (TECENTRIQ®) is Roche's anti-PD-L1 monoclonal antibodyThe clinical supply agreement will focus on evaluating PT217 in combination with atezolizumab for the...

at 17:30
Kyowa Kirin Will Present Pre-Clinical Data at the Association for Research in Vision and Ophthalmology Annual Meeting 2024
Kyowa Kirin Co., Ltd. (TSE: 4151) today announced that data from the pre-clinical pharmacokinetics & efficacy study comparing ocular tissue distribution after ocular instillation of tivozanib eye drops will be presented at the upcoming Association...

More news about Health...


News published on and distributed by: